Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Posted inAcquired Immune Deficiency Syndrome Africa Argentina Baluchistan (Pakistan) Brazil China Colombia Developing Countries Drugs (Pharmaceuticals) Epidemics Generic Brands and Products Gilead Sciences Inc Intellectual Property Inventions and Patents lenacapavir Medicine and Health Prices (Fares, Fees and Rates)

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Gilead Shot Provides Total Protection From HIV in Trial of Young African Women
Posted inAcquired Immune Deficiency Syndrome Africa Clinical Trials Developing Countries Drugs (Pharmaceuticals) Gilead Sciences Inc Medicine and Health Prices (Fares, Fees and Rates) Research South Africa Truvada (Drug) Uganda Viiv Healthcare Ltd Women and Girls your-feed-healthcare your-feed-science

Gilead Shot Provides Total Protection From HIV in Trial of Young African Women

An injection given just twice a year could herald a breakthrough in protecting the population that has the highest infection rates.
U.S. Lags Behind Other Countries in Hepatitis-C Cures
Posted inBiden, Joseph R Jr Centers for Disease Control and Prevention Collins, Francis S Disease Rates Drugs (Pharmaceuticals) Gilead Sciences Inc Hepatitis Infections Medicine and Health National Institutes of Health Prisons and Prisoners Tests (Drug Use)

U.S. Lags Behind Other Countries in Hepatitis-C Cures

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval.